<DOC>
	<DOCNO>NCT02184052</DOCNO>
	<brief_summary>Study determine safety efficacy Mobic® ampoules initiation treatment painful exacerbation osteoarthritis , rheumatoid arthritis similar painful inflammatory condition .</brief_summary>
	<brief_title>Safety Efficacy Mobic® Ampoules Initiation Treatment Painful Exacerbations Osteoarthritis , Rheumatoid Arthritis Other Similar Painful Inflammatory Conditions</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Meloxicam</mesh_term>
	<criteria>Painful acute exacerbation inflammatory rheumatism ( rheumatoid arthritis ankylose spondylitis ) , painful acute exacerbation osteoarthritis similar condition require acute treatment antiinflammatory drug</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>